Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
Int J Gynecol Cancer ; 26(2): 367-70, 2016 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-26588240

RESUMO

OBJECTIVE: The aim of this study was to compare the clinical presentation and incidence of postmolar gestational trophoblastic neoplasia (GTN) among cases of complete mole (CM) and partial mole (PM) from 1994 to 2013. METHODS: This study included all cases of patients with CM and PM from our trophoblastic disease center between 1994 and 2013. Their clinical and pathologic reports were reviewed. Gestational age at evacuation, features of clinical presentation, human chorionic gonadotropin levels, and the rate of progression to GTN were compared. RESULTS: The median gestational age at evacuation was 9 weeks for CM and 12 weeks for PM (P < 0.001). Patients with PM had lower pre-evacuation serum human chorionic gonadotropin levels (P < 0.001), and they were also less likely to present with vaginal bleeding (P < 0.001), biochemical hyperthyroidism (P < 0.001), anemia (P < 0.001), uterine size greater than dates (P < 0.001), and hyperemesis (P = 0.002). Consequently, patients with PM were less likely to have been clinically diagnosed as moles compared with CM prior to uterine evacuation (P < 0.001). The development of GTN occurred in 17.7% (33/186) and 4.1% (7/169) of patients with CM and PM, respectively (P < 0.001). CONCLUSIONS: This study indicates that, at our center over the past 20 years, both CM and PM were usually evacuated in the first trimester of pregnancy. Because CM more commonly presents with the signs and symptoms of molar disease than PM, CM is more commonly diagnosed prior to evacuation.


Assuntos
Doença Trofoblástica Gestacional/epidemiologia , Neoplasias Uterinas/epidemiologia , Adulto , Feminino , Humanos , New England/epidemiologia , Gravidez , Adulto Jovem
3.
Hematol Oncol Clin North Am ; 26(1): 111-31, 2012 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-22244665

RESUMO

Gestational trophoblastic neoplasms are malignant lesions that arise from placental villous and extravillous trophoblast. Four clinicopathologic conditions make up this entity: invasive mole (IM), choriocarcinoma (CCA), placental-site trophoblastic tumor (PSTT), and epithelioid trophoblastic tumor (ETT). IM and CCA, which make up the majority of these tumors, are highly responsive to chemotherapy with an overall cure rate exceeding 90%, making it usually possible to achieve cure while preserving reproductive function. PSTT and ETT, which rarely occur, are relatively resistant to chemotherapy, making surgery the primary treatment modality, chemotherapy being used only when the disease has metastasized.


Assuntos
Doença Trofoblástica Gestacional/terapia , Neoplasias do Sistema Nervoso Central/secundário , Neoplasias do Sistema Nervoso Central/terapia , Feminino , Seguimentos , Doença Trofoblástica Gestacional/diagnóstico , Doença Trofoblástica Gestacional/epidemiologia , Humanos , Neoplasias Hepáticas/secundário , Neoplasias Hepáticas/terapia , Neoplasias Pulmonares/secundário , Neoplasias Pulmonares/terapia , Estadiamento de Neoplasias , Gravidez , Complicações Neoplásicas na Gravidez/diagnóstico , Complicações Neoplásicas na Gravidez/terapia , Medição de Risco
4.
Gynecol Oncol ; 85(1): 204-8, 2002 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-11925147

RESUMO

BACKGROUND: Post-termchoriocarcinoma is a rare complication of pregnancy. The presence of epithelioid trophoblastic elements may lead to the persistence of locally invasive disease which is unresponsive to multiagent chemotherapy. Relapse is associated with an estimated mortality rate of 30%. CASE: We present a case of Stage IC post-term choriocarcinoma and epithelioid trophoblastic tumor. While the metastatic sites in the lungs responded to multiagent chemotherapy, a hysterectomy was required to treat persistent disease in the uterus. The patient relapsed within 4 months of completion of chemotherapy. Relapse was treated with high-dose chemotherapy with peripheral stem cell support. The patient is alive with no evidence of disease 23 months posttransplant. CONCLUSIONS: The application of multimodality treatment and high-dose chemotherapy resulted in a successful outcome for this patient, indicating a potential role for high-dose therapy in patients who suffer a relapse of choriocarcinoma.


Assuntos
Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico , Coriocarcinoma/terapia , Transplante de Células-Tronco Hematopoéticas , Neoplasias Trofoblásticas/terapia , Neoplasias Uterinas/terapia , Adulto , Protocolos de Quimioterapia Combinada Antineoplásica/administração & dosagem , Coriocarcinoma/tratamento farmacológico , Coriocarcinoma/cirurgia , Terapia Combinada , Ciclofosfamida/administração & dosagem , Dactinomicina/administração & dosagem , Relação Dose-Resposta a Droga , Etoposídeo/administração & dosagem , Feminino , Humanos , Histerectomia , Neoplasias Pulmonares/tratamento farmacológico , Neoplasias Pulmonares/secundário , Metotrexato/administração & dosagem , Gravidez , Neoplasias Trofoblásticas/tratamento farmacológico , Neoplasias Trofoblásticas/cirurgia , Neoplasias Uterinas/tratamento farmacológico , Neoplasias Uterinas/cirurgia , Vincristina/administração & dosagem
5.
Rev. mex. pediatr ; 54(5): 207-11, sept.-oct. 1987. tab
Artigo em Espanhol | LILACS | ID: lil-77407

RESUMO

Los periodos menstruales anovulatorios durante el primer año de posmenarquia o más, y los factores relacionados con la maduración sexual, además de los procesos patológicos, pueden producir sangramientos uterinos. Los nódulos mamarios son menos frecuentes, pero pueden provocar angustia, sobre todo entre jóvenes con antecedentes familiares de cáncer de mama


Assuntos
Hemorragia Uterina , Mama/patologia , Hemorragia Uterina/diagnóstico , Hemorragia Uterina/terapia , Mama/cirurgia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA